Le Lézard
Classified in: Health
Subjects: TRI, SCZ, DEI

Chinese Medical Journal Study Highlights Risks of Subpar Muscle Characteristics


BEIJING, Dec. 7, 2022 /PRNewswire/ -- Sarcopenia is a degenerative condition that tends to affect older people, and low muscle mass and strength are the main indicators. Could these indicators also be linked to the overall risk of dying?

This question has been the focus of various cohort studies, which explored the relationship between all-cause mortality and muscle mass-related measures, muscle strength, and muscle quality. However, most such studies were conducted in Western populations, and evidence from Asian populations is lacking, especially among Chinese people.

To tackle this knowledge gap, a team of scientists from China and the UK conducted a study aimed at comprehensively examining the associations of muscle mass, strength, and quality with the risk of death in China. Based on the China Kadoorie Biobank cohort, the study included 23,290 participants aged between 38 to 88 years who had no prevalent cardiovascular diseases or cancer and came from diverse economical and geographical backgrounds. Their results were published in Chinese Medical Journal on 5 June 2022.

The researchers measured muscle mass and grip strength using calibrated instruments, and calculated arm muscle quality as the ratio of grip strength to arm muscle mass. Then, participants were grouped as having either low or normal total muscle mass index, grip strength, and arm muscle quality, and both groups were compared across various characteristics via statistical regressions adjusted for age, sex, and study site.

The results showed that the short-term risk of all-cause mortality increased considerably for those with low appendicular muscle mass index, total muscle mass index, grip strength, and muscle quality, even after adjusting for sociodemographic and lifestyle factors and medical histories. Put simply, subpar muscular characteristics seem to translate to a higher risk of dying within a period of four years.

"Our findings indicate the importance of maintaining normal muscle mass, strength, and quality for general Chinese adults," remarks Associate Professor Canqing Yu of Peking University, who is the corresponding author of the study. "Grip strength and muscle mass index in the arm and trunk are of more clinical and public health relevance and should be given priority when assessing population mortality risk using different muscle metrics," he adds.

Another interesting finding was that, among Chinese adults, muscle mass in the arms or trunk seems to be better at predicting all-cause mortality than muscle mass in the legs. "Few studies have assessed the associations between muscle mass indices in different body parts and all-cause mortality," says Associate Professor Yu, highlighting one of the key strengths of the study.

Hopefully, the results will motivate Chinese adults to strive for good muscle mass and strength, saving lives in the process.

Reference

Title of original paper: Associations of muscle mass, strength, and quality with all-cause mortality in China: a population-based cohort study

Journal: Chinese Medical Journal

DOI: https://doi.org/10.1097/cm9.0000000000002193

Media Contact:
Peifang Wei
86-10-51322170
[email protected] 

SOURCE Chinese Medical Journal


These press releases may also interest you

at 01:30
PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the...

at 01:00
Management Report1 Q1 2024 highlights Strong performance in Perfumery & Beauty on good demand developmentGood performance in Taste, Texture & Health underpinned by market recoveryHealth, Nutrition & Care was soft, with improving momentum by end of...

at 00:01
Today, the Conference on Jewish Material Claims Against Germany (Claims Conference) launched a new digital campaign, #CancelHate. The campaign features Holocaust survivors reading Holocaust denial posts from across social media platforms. Each post...

at 00:00
With over four decades of nursing experience under her belt, Sherry Shaffer Ratajczak has witnessed firsthand the dedication of her colleagues in patient care. Yet, she observed a common misunderstanding: many are unaware of the extensive knowledge...

1 mai 2024
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

1 mai 2024
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...



News published on and distributed by: